Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-26

HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days ago

HgCapital Trust4 days ago

New Director · Appointment of ALI, Moynul as director · New director appointed · board evolution

admin

Treble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days ago

Treble Peak5 days ago

Share Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Compagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks ago

Compagnie Financière et de Participations Roullier2 weeks ago

Board change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin

Biotech USA

30 companies matching

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Capstan Therapeutics2 periods Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	2022	4yr	Active	–	–
Intarcia Therapeutics QCP Buyout Fund III	Biotech	USA	Quilvest Capital Partners	–	–	Exited 2023	i2O Therapeutics	–
Aldevron2 periods TA Associates Portfolio	Biotech	USA	TA Associates	2019	2yr	Active	–	–
Sirion2 periods Brookfield Growth Fund	Biotech	USA	Brookfield Asset Management	2006	15yr	Active	–	–
Moderna Aglaé Ventures	Biotech	USA	Aglaé Management	2018	3yr	Exited 2021	Public market (open market sale, 2021)	–
Pretzel Therapeutics5 periods Eir Ventures I	Biotech	USA	Eir Ventures	2021	5yr	Active	–	–
Cytosolix2 periods Backed Fund III	Biotech	USA	BACKED VC	2023	3yr	Active	–	–
Dewpoint Therapeutics2 periods Leaps by Bayer	Biotech	USA	Leaps by Bayer	2019	7yr	Active	–	–
Akero Therapeutics General Atlantic Growth Equity Fund	Biotech	USA	General Atlantic	–	–	Active	–	–
Alloy Therapeutics Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	–	–	Active	–	–
Atsena Therapeutics Abingworth Bioventures VII	Biotech	USA	Abingworth	2020	6yr	Active	–	–
Avid Bioservices GHO Capital IV LP	Biotech	USA	GHO Capital	2025	1yr	Active	–	–
BiOligo Biotechnology The Carlyle Group Portfolio	Biotech	USA	The Carlyle Group	–	–	Active	–	–
Caris Life Sciences Silver Lake Partners IV	Biotech	USA	Silver Lake	–	–	Active	–	–
EpiBiologics Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	–	–	Active	–	–
Genetix Biotherapeutics The Carlyle Group Portfolio	Biotech	USA	The Carlyle Group	–	–	Active	–	–
Georgiamune Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	–	–	Active	–	–
Juvena Therapeutics Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	–	–	Active	–	–
Mimetic Medicine AgFunder Fund IV	Biotech	USA	AgFunder	–	–	Active	–	–
Novogaia Backed Fund III	Biotech	USA	BACKED VC	2026	0yr	Active	–	–
Protera Sofinnova Industrial Biotech	Biotech	USA	Sofinnova Partners	2020	6yr	Active	–	–
SciNeuro General Atlantic Portfolio	Biotech	USA	General Atlantic	–	–	Active	–	–
Sensible Bio Backed Fund III	Biotech	USA	BACKED VC	2023	3yr	Active	–	–
Serna Bio Backed Fund III	Biotech	USA	BACKED VC	2023	3yr	Active	–	–
Advanced Cell Diagnostics Summit Partners Portfolio	Biotech	USA	Summit Partners	–	–	Active	–	–
Clontech Laboratories Summit Partners Portfolio	Biotech	USA	Summit Partners	–	–	Active	–	–
Fermentas International Summit Partners Growth Equity Fund VII	Biotech	USA	Summit Partners	–	–	Active	–	–
GC Therapeutics Mubadala Capital Other Investments	Biotech	USA	Mubadala Capital	–	–	Active	–	–
Integrated Dna Technologies Summit Partners Portfolio	Biotech	USA	Summit Partners	–	–	Active	–	–
Lakepharma Summit Partners Growth Equity Fund X	Biotech	USA	Summit Partners	–	–	Active	–	–

Portfolio companies.21,000+ PE-backed.

Portfolio companies.
21,000+ PE-backed.